Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Everything-But-CRM Growth Drivers Slow In Q2 For St. Jude

This article was originally published in The Gray Sheet

Executive Summary

Amid a persistently contracting cardiac rhythm management market, the firm’s CRM business, while not growing, performed better than expected in the second quarter. But several of it its non-CRM businesses, which the company relies on to drive growth, experienced a slowdown.

You may also be interested in...



St. Jude Confident In 2013 Growth Plan Despite Market Challenges

Anticipated growth drivers include the firm’s MediGuide catheter tracking system, EnligHTN multi-electrode renal denervation system and Portico transcatheter aortic valve, aided by a return to stability of the cardiac rhythm management market by the first half of 2013.

Medical Device Market & Industry Briefs, August 2012

Brief summaries of recent medtech market and industry developments. This month we cover continuing pressures on the DES and ICD markets, update Edwards’ efforts to roll out its Sapien device for TAVR, and report on QLT’s decision to sell its punctal plug technology.

St. Jude Medical Tags Device Tax As Acquisition Opportunity-Maker

The company is maintaining reserves so it can move forward with beneficial acquisition opportunities as they arise, opportunities that St. Jude executives think might become more frequent next year with the 2.3% device tax in place.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT031405

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel